Advancing wastewater & environmental surveillance for public health impact in Asia

Grant number: 101286993

Grant search

Key facts

  • Disease

    mpox
  • Start & end year

    2026
    2029
  • Known Financial Commitments (USD)

    $2,385,400
  • Funder

    European Commission
  • Principal Investigator

    Vincent Junxiong PANG
  • Research Location

    Singapore
  • Lead Research Institution

    NATIONAL UNIVERSITY OF SINGAPORE PUBLIC COMPANY LIMITED BY GUARANTEE
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies
  • Research Subcategory

    Disease surveillance & mapping
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable
  • Mpox Research Priorities

    N/A
  • Mpox Research Sub Priorities

    N/A

Abstract

This project aims to build on emerging lessons from existing regional network and partnerships (including EU-led programmes such as EU-WISH, the Wastewater Surveillance for Africa Initiative, and GLOWACON) to further develop regional wastewater surveillance guidance for Asia, and to support countries in the institutionalisation of wastewater surveillance systems that are appropriate, cost-efficient and have public health impact. The project will strengthen wastewater surveillance against the mpox outbreak, pathogen genomics capacities, data analytics, the network to support outbreak detection, and reinforce wastewater surveillance as a tool for health crisis management, as well as for pandemic preparedness against cross-border health threats. The project activities will include (a) co-developing a tailored multi-pathogen WES assay (including mpox) with World Health Organisation via the Preferred Product Characteristics mechanism, (b) Validating multi-pathogen WES assay for use in resource limited settings, (c) formalising agreement(s) with manufacturers on low-cost procurement models, (d) strengthening WES technical and innovation capacity including for mpox detection through Asia Pathogen Genomics Initiative Academy (in collaboration with the European Water Academy & GLOWACON) (e) generation of evidence and frameworks for national WES integration and public health impact through practical toolkit for national strategic planning, including guidance framework on legal and ethical dimensions of WES, and (f) cross-country exchange of knowledge and mapping and analysis of existing WES databases and dashboards in Asia.